Amgen Inc. Files 8-K for Security Holder Vote
Ticker: AMGN · Form: 8-K · Filed: May 27, 2025 · CIK: 318154
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: AMGN
TL;DR
Amgen's voting on important stuff soon, keep an eye out.
AI Summary
On May 23, 2025, Amgen Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing does not disclose specific details of the matters to be voted on, but it indicates that a vote will take place.
Why It Matters
This filing signals an upcoming shareholder meeting where important corporate decisions will be put to a vote, potentially impacting the company's future direction.
Risk Assessment
Risk Level: low — The filing is a routine procedural disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- Amgen Inc. (company) — Registrant
- May 23, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-37702 (commission_file_number) — SEC File Number
- 95-3540776 (irs_ein) — IRS Employer Identification No.
- One Amgen Center Drive (address) — Principal Executive Offices
- Thousand Oaks (city) — Principal Executive Offices
- California (state) — Principal Executive Offices
- 91320-1799 (zip_code) — Principal Executive Offices
- (805) 447-1000 (phone_number) — Registrant's Telephone Number
FAQ
What specific matters will be submitted to a vote of Amgen Inc.'s security holders?
The filing does not specify the exact matters to be voted on, only that matters are being submitted for a vote.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 23, 2025.
In which state is Amgen Inc. incorporated?
Amgen Inc. is incorporated in Delaware.
What is Amgen Inc.'s principal executive office address?
Amgen Inc.'s principal executive office is located at One Amgen Center Drive, Thousand Oaks, California, 91320-1799.
What is the SEC file number for Amgen Inc.?
Amgen Inc.'s SEC file number is 001-37702.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 27, 2025 regarding AMGEN INC (AMGN).